Saratov JOURNAL of Medical and Scientific Research

Investigation of the oxidative status in patients with Parkinson's disease

Year: 2018, volume 14 Issue: №1 Pages: 132-135
Heading: Neurology Article type: Original article
Authors: Goncharova Z.A., Kolmakova T.S., Okseniuk O.S., Gelpey M.A., Isachkina N.S.

Currently, much attention is paid to the search for laboratory diagnostic tests for Parkinson's disease, which can be used to create a screening diagnostic panel. The aim of the research was to study markers of oxidative status in blood plasma and to correlate these indicators with the main clinical characteristics of Parkinson's disease. Material and Methods. The study included 32 patients of the main group and 21 patients as a control group. Blood was collected for the evaluation of total oxidative activity and general antioxidant status of the organism (OOAand OAA): determination of the activity of catalase, superoxide dismutase (SOD), malonic dialdehyde (MDA) in the blood serum by spectropho- tometric method. Results. The parameters of SOD, catalase, ОАА, OOA in patients with early stage of Parkinson's disease significantly differed from those of the control group Conclusion. Reduction of oxidative activity could slow down the development of the disease.

1 Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord 2015; 30: 1591-1601
2 Goncharova ZA, Chernikova IV, Rabadanova EA, et al. Modern aspects of epidemiology and early diagnosis of Parkinson's disease. Meditsinskiy vestnik Yuga Rossii 2014; (3): 15-21
3 Goncharova ZA, Rabadanova EA, Gelpey MA. Non-motor symptoms of Parkinson's disease, their structure and impact on the quality of patients' life. Practical medicine 2015; 9 (5): 111-115
4 Braak Н, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211
5 Gaig C, Tolosa E. When does Parkinson's disease begin? Mov Disord 2009; 24: 656-664
6 Postuma RB, et al. Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease. Mov Disord 2012;27:617-626
7 Goncharova ZA, Kolmakova TS, Gelpey MA. Alpha-Synuclein and Oxidative Stress Enzymes as Biomarkers of Parkinson's Disease. Neurochemical Journal 2017; 34 (2): 99-107
8 Alvarez-Erviti L, Rodriguez-Oroz МС, Cooper JM, et al. Chaperone-mediated autophagy markers in Parkinson disease brains. Arch Neurol 2010; 67: 1464-1472
9 Schapira AH. Mitochondrial pathology in Parkinson's disease. Sinai J Med 2011; 78: 72-81
10 Shadrina Ml, Slominskiy PA. The importance of mitochondrial dysfunction and oxidative damage in the molecular pathology of Parkinson's disease. Molecular Biology 2008; 42 (5): 809-819
11 Dorsey ER, Constantinescu R. Projected number of people with Parkinson's disease in the most populous nations, 2005 through 2030 Neurology 2007; (68): 384-386
12 Buneeva OA, Medvedev AE. Disturbance of mitochondrial function in Parkinson's disease. Biomedical Chemistry 2011; 57 (3): 246
13 BobelaW, Aebischer Р, Schneider BL. Alpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson's Disease. Biomolecules 2015; 5 (4): 2675-2700.

2018_01-1_132-135.pdf241.66 KB

No votes yet